We leverage a platform based on generic drug development and consistency evaluation services, highlighting our strengths in specialization and efficiency. Our expertise spans multiple dosage forms, including oral solid formulations, inhalation formulations, topical formulations, eye drops, and injections.

Meanwhile, we continuously integrate upstream and downstream R&D value chain modules to deliver high-quality, comprehensive services in chemical drug CRO and CDMO.

To date, we have developed over 200 projects, with more than 30 approvals granted. We offer full-spectrum services and expert support across CRO, CMO, CDMO, innovative drug development, and modified new drug development.

Our achievements include the first project approved through consistency evaluation and multiple successful on-site inspections by NMPA. Backed by a strong foundation in pharmaceutical research and extensive experience in generic drug development and consistency evaluation projects, our R&D team ensures high-quality and efficient service delivery.